$ASAZY Congressional Stock Tracker 1 Member

$ASAZY · ASSA ABLOY AB (publ) Congress Trades

1 members of the U.S. Congress (0 Senators and 1 Representatives) have disclosed 3 STOCK Act transactions in ASSA ABLOY AB (publ) ($ASAZY) between Aug 21, 2023 and Jul 9, 2024, totaling 2 purchases and 1 sales. Members who have traded $ASAZY include Josh Gottheimer.

Total Congress Trades3
Members Trading1
Purchases2
Sales1
Senate / House0S · 1H
Latest DisclosureJul 9, 2024
Disclosed Jul 9, 2024 · Official PDF ↗

Hon. Josh Gottheimer conducted extensive portfolio rebalancing in June 2024, executing numerous sales (predominantly partial positions) across a diversified portfolio of domestic and international stocks worth $1,001-$15,000 each, while making selective purchases in Apple (AAPL), Broadcom (AVGO), Grupo Financiero Banorte (GBOOY), Intuitive Surgical (ISRG), Microsoft (MSFT), NVIDIA (NVDA), and Advanced Energy Industries (AEIS).

Disclosed Sep 16, 2023 · Official PDF ↗

Rep. Josh Gottheimer (NJ-05) executed a highly active trading portfolio in August 2023, including significant options activity in Microsoft (MSFT) with $1M-$5M in purchases and sales of call options at various strike prices, along with numerous stock purchases and partial sales across tech, healthcare, and industrial sectors ranging from $1,001-$50,000 each. All transactions were managed through Morgan Stanley accounts and reported on 09/07/2023.

Member of Congress Action Amount Range Traded Disclosed Owner Filing
Rep. Josh Gottheimer
House · NJ05
Sale $1,001 - $15,000 Jun 21, 2024 Jul 9, 2024 Joint PTR PDF ↗
Rep. Josh Gottheimer
House · NJ05
Purchase $1,001 - $15,000 Aug 22, 2023 Sep 16, 2023 Joint PTR PDF ↗
Rep. Josh Gottheimer
House · NJ05
Purchase $1,001 - $15,000 Aug 21, 2023 Sep 16, 2023 Joint PTR PDF ↗

Track when Congress trades $ASAZY and your other holdings.

Free weekly digest and real-time alerts for U.S. Senate and House STOCK Act disclosures — plus portfolio tracking that ties congressional activity to your positions.

Start your free trial →